Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
3M Cavilon Barrier Film is a terpolymer-based, alcohol-free liquid barrier film designed to protect intact or damaged skin from irritation caused by bodily fluids (such as urine and feces), wound exudate, adhesives, friction, and shear. Upon application to the skin—via wand, wipe, or spray—it dries rapidly to form a transparent, breathable coating that provides up to 72 hours of protection. The film is non-cytotoxic and hypoallergenic; it does not interfere with wound healing or absorbency of dressings. Its mechanism of action is physical—creating a protective interface between the skin and external irritants—rather than pharmacological. It is suitable for use in adults, children, and infants over one month old[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 3M Cavilon Barrier Film.